Vendeur : Ammareal, Morangis, France
EUR 6,17
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Très bon. Ancien livre de bibliothèque. Légères traces d'usure sur la couverture. Salissures sur la tranche. Edition 2004. Tome 1. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Slight signs of wear on the cover. Stains on the edge. Edition 2004. Volume 1. Ammareal gives back up to 15% of this item's net price to charity organizations.
Vendeur : Ammareal, Morangis, France
EUR 6,49
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Très bon. Ancien livre de bibliothèque. Légères traces d'usure sur la couverture. Salissures sur la tranche. Edition 2004. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Slight signs of wear on the cover. Stains on the edge. Edition 2004. Ammareal gives back up to 15% of this item's net price to charity organizations.
EUR 36,04
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. pp. 376 1st Edition.
EUR 32,08
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. pp. 376.
Vendeur : Basi6 International, Irving, TX, Etats-Unis
EUR 40,02
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
EUR 42,03
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
EUR 42,03
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
EUR 31,53
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. pp. 376.
EUR 43,32
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
EUR 43,35
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
EUR 43,35
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
EUR 44,66
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
EUR 90,22
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. pp. 600 1st Edition.
EUR 90,04
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. pp. 600.
EUR 93,51
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. pp. 600.
Edité par Humana Press, Totowa, NJ, 2004., 2004
Vendeur : My Dead Aunt's Books, Hyattsville, MD, Etats-Unis
EUR 43,66
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Very Good. First ed. in pristine condition; pages immaculate and unmarked; bindings tight; glossy pictorial boards show minimal shelf wear despite absence of d.j.s; b & w ill. Vol. I, "Detection, Genotypes and Characterization"has 349 p and Vol. II, "Immunology, Model Systems and Clinical Studies" has 572 p. Inserts comprise a letter to former owner, a physician, asking him to review the volumes forr the Clinical Chemistry journal, and forms for assignment of copyright for the reviews.
Vendeur : Revaluation Books, Exeter, Royaume-Uni
EUR 141,72
Quantité disponible : 2 disponible(s)
Ajouter au panierPaperback. Etat : Brand New. reprint edition. 572 pages. 9.00x6.00x1.25 inches. In Stock.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 161,54
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Vendeur : preigu, Osnabrück, Allemagne
EUR 104,15
Quantité disponible : 5 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Hepatitis B and D Protocols | Volume 2: Immunology, Model Systems, and Clinical Studies | Johnson Y. N. Lau (u. a.) | Taschenbuch | xxiii | Englisch | 2010 | Humana | EAN 9781617373633 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 163,94
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Langue: anglais
Edité par Springer, 2004
Vendeur : Books in my Basket, New Delhi, Inde
EUR 165,42
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : New. ISBN:9781588291080.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 173,55
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Langue: anglais
Edité par Springer, 2004
Vendeur : Books in my Basket, New Delhi, Inde
EUR 177,25
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : New. ISBN:9781588291059.
EUR 198,10
Quantité disponible : 15 disponible(s)
Ajouter au panierEtat : New. This work discusses the significant worldwide health burden of hepatitis B virus (HBV) and hepatitis delta virus (HDV) in two volumes; reviews research techniques used in the study of HBV and HDV; and provides detailed descriptions of techniques that can be easily reproduced. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 572 pages, biography. BIC Classification: MMFM. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 32. Weight in Grams: 1162. . 2004. Hardback. . . . .
EUR 194,96
Quantité disponible : 15 disponible(s)
Ajouter au panierEtat : New. This title discusses the significant worldwide health burden of hepatitis B virus (HBV) and hepatitis delta virus (HDV). It reviews research techniques used in the study of HBV and HDV and provides detailed descriptions of techniques that can be easily reproduced. Editor(s): Hamatake, Robert K.; Lau, Johnson Y. N. Series: Methods in Molecular Medicine. Num Pages: 376 pages, 109 black & white illustrations, 1 colour illustrations, biography. BIC Classification: MJJ. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 229 x 152 x 25. Weight in Grams: 725. . 2004. Hardback. . . . .
Vendeur : UK BOOKS STORE, London, LONDO, Royaume-Uni
EUR 211,18
Quantité disponible : 3 disponible(s)
Ajouter au panierHardcover. Etat : New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 7-12 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
EUR 188,95
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Langue: anglais
Edité par Humana Press, Humana Press Jan 2004, 2004
ISBN 10 : 1588291057 ISBN 13 : 9781588291059
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
EUR 160,49
Quantité disponible : 2 disponible(s)
Ajouter au panierBuch. Etat : Neu. Neuware -Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge. For example, the major etiology of hepatocellular carcinoma (HCC) is chronic infection with HBV. Although fifth in cancer incidence, worldwide, HCC/liver cancer is the third leading cause of cancer death. The high mortality as- ciated with HCC arises because the disease is often detected late and is unresponsive to treatment. The number of deaths caused by PHCC is expected to rise over the next 20 years. Those chronically infected with HBV have a life risk of death to HCC of between 10 and 25%. Even the limited efficacy of drugs for the treatment of chronic HBV helps underscore the point that this disease is responsive to therapy. Drugs that target the polymerase (e. g. , hepsera and lamivudine) and interferon alpha represent two distinct strategies and show that both conventional antiviral and immunothe- peutic approaches can be used in management. However, the current inventory of therapeutics is inadequate. Interferon alpha is of limited value, only parenterally ava- able, and fraught with adverse reactions. 376 pp. Englisch.
Langue: anglais
Edité par Humana Press, Humana Press Jan 2004, 2004
ISBN 10 : 1588291081 ISBN 13 : 9781588291080
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
EUR 160,49
Quantité disponible : 2 disponible(s)
Ajouter au panierBuch. Etat : Neu. Neuware -Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge. For example, the major etiology of hepatocellular carcinoma (HCC) is chronic infection with HBV. Although fifth in cancer incidence, worldwide, HCC/liver cancer is the third leading cause of cancer death. The high mortality as- ciated with HCC arises because the disease is often detected late and is unresponsive to treatment. The number of deaths caused by PHCC is expected to rise over the next 20 years. Those chronically infected with HBV have a life risk of death to HCC of between 10 and 25%. Even the limited efficacy of drugs for the treatment of chronic HBV helps underscore the point that this disease is responsive to therapy. Drugs that target the polymerase (e. g. , hepsera and lamivudine) and interferon alpha represent two distinct strategies and show that both conventional antiviral and immunothe- peutic approaches can be used in management. However, the current inventory of therapeutics is inadequate. Interferon alpha is of limited value, only parenterally ava- able, and fraught with adverse reactions. 600 pp. Englisch.
Vendeur : UK BOOKS STORE, London, LONDO, Royaume-Uni
EUR 224,39
Quantité disponible : 3 disponible(s)
Ajouter au panierHardcover. Etat : New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 7-12 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.